glp 1 receptor agonist GLP-1 agonists show promise in treating substance use disorders GLP1 Receptor Agonists—Effects beyond Obesity
Description
doi: 10.1016/j.brainres.2018.04.031 207 WilkinsonM
Liraglutide attenuates cardiac remodeling and improves heart function after abdominal aortic constriction through blocking angiotensin II type 1 receptor in rats
Key Challenges Clinicians Should Prepare For Although more affordable GLP-1 therapies could improve access, several concerns remain
However, these medications also face several challenges, including low stability in the body, short half-lives, poor membrane permeability, complex manufacturing processes, and high costs
Bao Y, Jiang L, Chen H, Zou J, Liu Z, Shi Y
